Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLikewise Group Regulatory News (LIKE)

Share Price Information for Likewise Group (LIKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 14.00
Ask: 15.00
Change: 0.00 (0.00%)
Spread: 1.00 (7.143%)
Open: 14.50
High: 14.80
Low: 14.50
Prev. Close: 14.50
LIKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Open Offer

10 Jan 2022 07:00

RNS Number : 8862X
Likewise Group PLC
10 January 2022
 

10 January 2022

 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Likewise Group plc

("Likewise" or the "Group")

 

Result of Open Offer

 

 

Likewise Group plc (AIM:LIKE), the distributor of residential and commercial flooring to retailers and contractors is pleased to announce that it has raised gross proceeds of £2.0 million, pursuant to the Open Offer, as set out in the Circular dated 17 December 2021.

 

The Company has received valid acceptances from Qualifying Shareholders under their Basic Entitlements in respect of 2,307,936 Open Offer Shares and applications from Qualifying Shareholders under the Excess Application Facility in respect of 15,022,568 Open Offer Shares, representing in aggregate approximately 303.3% of the Open Offer Shares.

 

As set out in the Circular, the Placing and Open Offer was structured such that if the Open Offer was not fully subscribed, the number of Open Offer Shares for which valid applications were not received, would instead be placed with institutional investors pursuant to the Clawback Placing. Due to the Open Offer being over-subscribed, no funds will be raised pursuant to the Clawback Placing.

The Board greatly appreciates this support from its shareholders and, recognising the significant scale back necessarily applied to shareholder applications under the excess entitlement of the Open Offer, the Board proposes that the Open Offer is increased such that a further 5,714,286 Open Offer Shares ("Extended Open Offer Shares") of the total applications for 17,330,504 Open Offer Shares be issued (the "Extended Open Offer"). This will increase the gross proceeds raised under the open offer to £4.0 million and subject to Shareholder approval and the satisfactory completion of certain other conditions, the Group is expecting to have raised a total of £16.0 million comprising £12.0 million from the Firm Placing, £2.0 million from the Open Offer and £2.0 million from the Extended Open Offer.

The Company will inform shareholders of their initial excess allotment under the Open Offer and will be writing to this limited number of shareholders on 11 January 2022 asking them to inform the Company if they do not wish the Company to utilise a proportion of their surplus funds being held as part of their original excess application for Open Offer Shares. Further details will be set out in the letter, but should Shareholders not wish to maintain their application for the Extended Open Offer Shares, they should contact the Company at openoffer@likewiseplc.com by 5:30 p.m. on 26 January 2022. If no reply is received the Company will assume that the shareholder has accepted the proposal and confirmed their wish to apply for new Ordinary Shares as aforementioned and will allot the shares by using the funds held by the Registrars, with the remaining funds being returned to the shareholder.

General Meeting

The Placing and Open Offer remain conditional on the approval by Shareholders of Resolutions 1 and 2 at the Company's General Meeting to be held later today, the satisfaction of certain conditions in the Placing and Open Offer Agreement and admission of the New Ordinary Shares to trading on AIM occurring at or before 8.00 a.m. on 11 January 2022 (or such later date as the Company, Zeus and Ravenscroft may agree, being not later than 8.00 a.m. on 28 February 2022).

The results of the General Meeting will be made as soon as practicable following the conclusion of the General Meeting.

The issuance of the Extended Open Offer Shares will not be subject to further Shareholder approval and it is expected that the Extended Open Offer Shares will be admitted to trading on AIM on or around 1 February 2022.

For further information, please contact:

Likewise Group plc

Tony Brewer, Chief Executive

Roy Povey, Chief Financial Officer

 

Tel: 0121 871 2900

Zeus Capital Limited (Nominated Adviser & Joint Broker)

Jordan Warburton / David Foreman / James Edis (Corporate Finance)

Dominic King (Corporate Broking) 

 

Tel: 0203 829 5000

Ravenscroft Consultancy & Listing Services Limited (Joint Broker)

Semelia Hamon (Corporate Finance)

Tel: 01481 732 746

Novella Communications (Financial PR)

Fergus Young / Tim Robertson

Tel: 0203 151 7008

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROIUPUUPGUPPPGB
12
Date   Source Headline
28th May 20247:00 amRNSDirector Dealing
23rd May 20247:00 amRNSAnnual Report and Notice of AGM
20th May 20247:00 amRNSFY23 Audited Final Results
9th May 20247:00 amRNSExercise of Options, Issue of Shares and TVR
7th May 20247:00 amRNSNotice of Results and Investor Presentation
17th Apr 20245:22 pmRNSPDMR Shareholding
2nd Apr 20247:01 amRNSHolding(s) in Company
2nd Apr 20247:00 amRNSHolding(s) in Company
20th Mar 202410:24 amRNSPDMR Dealing
13th Mar 20247:00 amRNSExercise of Options, Issue of Shares and TVR
7th Mar 20247:00 amRNSPDMR Dealing
6th Mar 20247:00 amRNSTrading Update
5th Mar 20242:19 pmRNSDirector Dealing
17th Jan 20247:00 amRNSSettlement of Contingent Consideration
4th Jan 20247:00 amRNSTrading Update
19th Dec 20237:00 amRNSGrant of Options
7th Dec 20237:00 amRNSDirector and PDMR Dealings
6th Dec 20237:00 amRNSTrading Update
26th Oct 20237:00 amRNSAppointment of Joint Broker
29th Sep 20237:00 amRNSInterim Results
22nd Sep 20231:27 pmRNSInvestor Presentation via Investor Meet Company
5th Sep 20237:00 amRNSGrant of Options, SAYE Exercise & TVR
17th Aug 20239:14 amRNSHolding(s) in Company
27th Jul 20239:44 amRNSDirector and PDMR Dealings
29th Jun 20231:39 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement, Trading Update & Notice of Results
30th May 20237:00 amRNSTrading and Operations Update
25th May 202312:16 pmRNSPDMR Dealing
19th May 20237:00 amRNSAnnual Report and Notice of Annual General Meeting
16th May 20237:00 amRNSFinal Results
25th Apr 20234:21 pmRNSEmployee SAYE, Issue of Ordinary Shares and TVR
4th Apr 20237:00 amRNSTrading Update & Notice of Results
31st Mar 20237:00 amRNSInvestor Presentation
10th Mar 202312:27 pmRNSDirector Dealing
12th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSInvestor Presentation
1st Dec 20227:00 amRNSTrading Update
28th Oct 20222:05 pmRNSSecond Price Monitoring Extn
28th Oct 20222:00 pmRNSPrice Monitoring Extension
28th Oct 202211:05 amRNSSecond Price Monitoring Extn
28th Oct 202211:00 amRNSPrice Monitoring Extension
28th Oct 20229:05 amRNSSecond Price Monitoring Extn
28th Oct 20229:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSTrading Update
26th Sep 20227:01 amRNSGrant of Options
26th Sep 20227:00 amRNSInterim Results
1st Sep 20224:10 pmRNSSAYE Exercise & Total Voting Rights
11th Jul 20227:00 amRNSDirector and PDMR Dealing
7th Jul 20224:19 pmRNSResult of General Meeting
30th Jun 20223:41 pmRNSResult of AGM
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.